Work

555 Cancer Risk After Therapeutic Glp-1 Receptor Agonist Use Compared With Bariatric Surgery and Other Weight-loss Drugs

Year: 2026

Type: article

Source: Gastroenterology

DOI: 10.1016/s0016-5085(26)04789-x

Authors: Elio R. Bitar, Karim Besir, Kaelyn C. Cummins, Olivia Sears, Mohamad El Moheb, Kellyn E. McKee, Samantha Ruff, Dirk J. van der Windt, Allan Tsung

Language: English

Topic: Bariatric Surgery and Outcomes

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7160144572

FWCI:

Cites:

Cited by:

Related to: 10